| 20-Aug-2008 | S | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 20, 2008, inter alia, has considered the following:
To consolidate the equity shares of face value of Rs 2/- each to face value of Rs 10/- each subject to approval of shareholders at ensuing AGM.
SUB. :- Consolidation of Equity Shares of Lincoln Pharmaceuticals Limited (Scrip Code 531633)
Trading Members of the Exchange are hereby informed that, Lincoln Pharmaceuticals Limited has fixed the Record Date for the purpose of Consolidation of the equity shares of the company. Trading members of the Exchange are hereby advised not to deal in the Equity Shares of the Company as mentioned here under.
COMPANY NAME CODE
Lincoln Pharmaceuticals Limited
(531633)
RECORD DATE
26/03/2009
PURPOSE
Consolidation of existing equity shares from every FIVE equity shares of Rs.2/- each into ONE equity share of Rs.10/- each.
NO DEALINGS FROM
19/03/2009 DR-237/2008 - 2009
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 12.03.2009) | 26-Mar-2009 | |
| 31-Jan-2006 | S | Sub Division of Equity shares From Rs.10/-each to Rs.2/- each.
(As per BSE Bulletin dated on 19/12/2005)
EGM 23/01/2006
To consider and approve inter-alia, sub-division of equity share from Rs 10/- each into equity
share of Rs 2/ each, consequent amendment in capital clause of Memorandum of Association
of the Company.
(As per BSE Bulletin dated on 26/12/2005)
The company has informed that the members at the Extra Ordinary General Meeting (EGM) of the Company held on January 23, 2006, have approved the following:
1. Sub-division of equity shares of face value for Rs 10/- in to face value of Rs 2/- each and consequential amendment in the Capital clause of Memorandum of Association of the Company.
(As per BSE Bulletin dated on 24/01/2006)
Trading members of the Exchange are hereby informed that, Lincoln Pharmaceuticals Limited has fixed the Record Date for the purpose of sub division.
RECORD DATE 16/02/2006
REDUCED PAID-UP VALUE Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F. 08/02/2006
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each fully paid up into FIVE equity shares of Rs.2/- each fully paid up.
The auction in the equity shares of Lincoln Pharmaceuticals Limited in Dematerialised Securities - Rolling Settlement Segment on 08/02/2006, 10/02/2006 and 13/02/2006 will be conducted as per face value of Rs.10/- each. Trading members are, therefore, requested to
take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be No Delivery from 08/02/2006 (DR-218/2005-2006) to 15/02/2006 (DR-222/2005-2006).
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs.2/- paid up w.e.f. 08.02.2006.
ii. ISIN No. INE405C01019 of Rs.10/- paid up will be discontinued w.e.f. 08.02.2006 and the new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As per BSE Notice dated on 31/01/2006) | 16-Feb-2006 | |
| 25-May-2023 | D | Recommended a dividend of 1.50/- (i.e. 15% per share) per equity share of face value of 10/- for the year ended March 31, 2023, for approval of the members at the ensuring annual general meeting (AGM) of the Company | 15-Sep-2023 | |
| 19-May-2022 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 19, 2022, inter alia, has recommended a dividend of Rs. 1.50/- (i.e. 15% per share} per equity share of face value of Rs. 10/- for the year ended March 31, 2022, for approval of the members at the ensuring annual general meeting (AGM) of the Company. | 15-Sep-2022 | |
| 25-May-2021 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2021, inter alia, has recommended a dividend of Rs. 1.50/- (i.e. 15% per share) per equity share of face value of Rs. 10.00/- for the year ended March 31, 2021, for approval of the members at the ensuring Annual General Meeting (AGM) of the Company.
| 16-Sep-2021 | |
| 27-Feb-2020 | D | we have to inform you that the meeting of Board of Directors of the Company held today, i.e. February 27, 2020, inter-alia consider :
Approved and declared the payment of Interim Dividend of Rs. 1.50 (One Rupee and Fifty Paisa only) Per Share of Face Value of Rs. 10/- Each for the Financial Year 2019-2020. (i.e. 15% Per Share). | 05-Mar-2020 | |
| 30-May-2019 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 30, 2019, inter alia, has recommended the Dividend of Rs. 1.50 (@ 15%) Per Share of Face Value of Rs. 10/- Each of the Company, subject to the approval of Shareholders at the Ensuring Annual General Meeting. | 19-Sep-2019 | |
| 30-May-2018 | D | The Board of Directors of the Company at their meeting held today, i.e. on May 30, 2018 had considered and Recommended the Dividend of Rs. 1.50/- (@ 15%) Per Share of Face Value of Rs. 10/- Each of the Company, subject to the approval of Shareholders at the Ensuring Annual General Meeting. | 19-Sep-2018 | |
| 30-May-2017 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2017, inter alia, has recommended the Dividend of Rs. 1.20 (@ 12%) per Share of Face Value of Rs. 10/- each of the Company, subject to the approval of Shareholders at the Annual General Meeting. | 21-Sep-2017 | |
| 30-May-2016 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, has recommended the Dividend of Rs. 1/- (@10%) per Equity Share of face value of Rs. 10/- each.
The meeting of the Board of Directors of the Company commenced at 11.45 a.m. and concluded at 1.05 p.m. | 23-Sep-2016 | |
| 30-May-2015 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has:
1. Recommended dividend of Re. 1.00(10%) per Equity Share of face value Rs. 10/- each.
| 23-Sep-2015 | |
| 31-May-2014 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommended the payment of Dividend of Rs. 0.60/- per equity share (@ 6%) of face value of Rs. 10/- each of the Company for the year 2013-14 subject to approval of the shareholders in the Annual General Meeting. | 25-Sep-2014 | |
| 30-May-2013 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has recommended the payment of Dividend of Rs. 0.60 (@ 6%) per equity share of f.v. Rs. 10/- each of the Company. | 19-Sep-2013 | |
| 14-Aug-2012 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 14, 2012, inter alia, has recommended the payment of Dividend @ Rs. 0.60/- per equity share (6%) on face value of Rs. 10/- each for the year 2011-12. | 20-Sep-2012 | |
| 31-May-2011 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2011, inter alia, has recommended the payment of Dividend of Rs. 0.60 per equity share (@ 6%) of face Value of Rs. 10/- each of the Company. for the year 2010-11, subject to approval of the shareholders in the Annual General Meeting. | 22-Sep-2011 | |
| 19-Aug-2010 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 19, 2010, inter alia, has recommended the payment of Dividend @ Rs. 1.20/- per equity share of face value of Rs. 10/- each (@12%) for the year 2009-10. | 23-Sep-2010 | |
| 31-Aug-2009 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 31, 2009, inter alia, has considered the following:
1. Recommended the payment of Dividend @ Rs. 1.20/- per equity share of Rs. 10/- each (@ 12%) for the year 2008-09. | 17-Sep-2009 | |
| 20-Aug-2008 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 20, 2008, inter alia, has considered the following:
Recommended the payment of Dividend @ 12% for the year 2007-08. | 18-Sep-2008 | |
| 30-Aug-2007 | D | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 30, 2007, inter alia, has approved the final Dividend @ 12% on face value of Rs 2/- per share for the financial year ended on March 31, 2007. | 20-Sep-2007 | |
| 24-Mar-2007 | D | 12% Interim Dividend | 14-Sep-2006 | |
| 25-Aug-2005 | D | 12% Dividend | 25-Aug-2005 | |
| 01-Apr-2024 | BC | Board Meeting Outcome for Appointment of Non-Executive Independent Directors and Approval of Postal Ballot.
In compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached | 18-May-2024 | |
| 01-Apr-2024 | BC | Board Meeting Outcome for Appointment of Non-Executive Independent Directors and Approval of Postal Ballot. | 01-Apr-2024 | |
| 01-Apr-2024 | BC | Board Meeting Outcome for Appointment of Non-Executive Independent Directors and Approval of Postal Ballot. | 01-Apr-2024 | |
| 30-Mar-2024 | BC | Mr. Pirabhai Suthar will complete his second and final term as an Independent Director of the Company and consequently ceased to be Director of the Company w.e.f closing of business hours on March 31 | 31-Mar-2024 | |
| 29-Feb-2024 | BC | Patel Nishitkumar Mahesbhai | 27-Feb-2024 | |